Foster Dykema Cabot & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $21.6M | Sell |
42,640
-18
| -0% | -$9.11K | 2.61% | 10 |
|
|
2023
Q2 | $22.3M | Buy |
42,658
+255
| +0.6% | +$133K | 2.62% | 11 |
|
|
2023
Q1 | $24.4M | Buy |
42,403
+1,030
| +2% | +$594K | 3.14% | 6 |
|
|
2022
Q4 | $22.8M | Sell |
41,373
-926
| -2% | -$510K | 3.19% | 4 |
|
|
2022
Q3 | $21.5M | Buy |
42,299
+86
| +0.2% | +$43.6K | 2.69% | 5 |
|
|
2022
Q2 | $22.9M | Sell |
42,213
-168
| -0.4% | -$91.3K | 2.83% | 5 |
|
|
2022
Q1 | $25M | Buy |
42,381
+131
| +0.3% | +$77.4K | 3.02% | 9 |
|
|
2021
Q4 | $28.2M | Buy |
42,250
+1,104
| +3% | +$737K | 3.18% | 5 |
|
|
2021
Q3 | $23.5M | Sell |
41,146
-326
| -0.8% | -$186K | 2.93% | 5 |
|
|
2021
Q2 | $20.9M | Buy |
41,472
+545
| +1% | +$275K | 2.61% | 9 |
|
|
2021
Q1 | $18.7M | Buy |
40,927
+587
| +1% | +$268K | 2.52% | 9 |
|
|
2020
Q4 | $18.8M | Sell |
40,340
-4,234
| -9% | -$1.97M | 2.64% | 8 |
|
|
2020
Q3 | $19.7M | Buy |
44,574
+303
| +0.7% | +$134K | 3.23% | 8 |
|
|
2020
Q2 | $16M | Sell |
44,271
-190
| -0.4% | -$68.8K | 2.9% | 8 |
|
|
2020
Q1 | $12.6M | Buy |
44,461
+1,880
| +4% | +$533K | 2.44% | 11 |
|
|
2019
Q4 | $13.8M | Buy |
42,581
+8,262
| +24% | +$2.68M | 1.94% | 14 |
|
|
2019
Q3 | $10M | Buy |
34,319
+919
| +3% | +$268K | 1.48% | 19 |
|
|
2019
Q2 | $9.81M | Buy |
33,400
+649
| +2% | +$191K | 1.48% | 19 |
|
|
2019
Q1 | $8.97M | Buy |
+32,751
| New | +$8.97M | 1.45% | 18 |
|